ATE518546T1 - Zusammensetzungen enthaltend myelin-basisches protein peptiden und medizinische verwendungen - Google Patents
Zusammensetzungen enthaltend myelin-basisches protein peptiden und medizinische verwendungenInfo
- Publication number
- ATE518546T1 ATE518546T1 AT08844568T AT08844568T ATE518546T1 AT E518546 T1 ATE518546 T1 AT E518546T1 AT 08844568 T AT08844568 T AT 08844568T AT 08844568 T AT08844568 T AT 08844568T AT E518546 T1 ATE518546 T1 AT E518546T1
- Authority
- AT
- Austria
- Prior art keywords
- basic protein
- myelin basic
- compositions containing
- protein peptides
- medical uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0721430A GB0721430D0 (en) | 2007-10-31 | 2007-10-31 | Composition |
GB0800962A GB0800962D0 (en) | 2008-01-18 | 2008-01-18 | Conposition |
PCT/GB2008/003673 WO2009056833A2 (en) | 2007-10-31 | 2008-10-30 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE518546T1 true ATE518546T1 (de) | 2011-08-15 |
Family
ID=40591554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08844568T ATE518546T1 (de) | 2007-10-31 | 2008-10-30 | Zusammensetzungen enthaltend myelin-basisches protein peptiden und medizinische verwendungen |
Country Status (24)
Country | Link |
---|---|
US (3) | US8623827B2 (de) |
EP (1) | EP2211892B1 (de) |
JP (1) | JP5361895B2 (de) |
KR (1) | KR101570383B1 (de) |
CN (1) | CN101848725B (de) |
AT (1) | ATE518546T1 (de) |
AU (1) | AU2008320657B2 (de) |
BR (1) | BRPI0818302B1 (de) |
CA (1) | CA2703170C (de) |
CY (1) | CY1112620T1 (de) |
DK (1) | DK2211892T3 (de) |
EA (1) | EA017999B1 (de) |
EC (1) | ECSP10010211A (de) |
HK (1) | HK1142803A1 (de) |
HR (1) | HRP20110724T1 (de) |
IL (1) | IL204662A (de) |
MX (1) | MX2010004698A (de) |
MY (1) | MY158800A (de) |
NZ (1) | NZ583924A (de) |
PL (1) | PL2211892T3 (de) |
PT (1) | PT2211892E (de) |
SI (1) | SI2211892T1 (de) |
WO (1) | WO2009056833A2 (de) |
ZA (1) | ZA201001748B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230233B1 (hu) | 2000-08-21 | 2015-10-28 | Apitope Technology (Bristol) Limited | Peptid szelekciós módszer |
PT2211892E (pt) | 2007-10-31 | 2011-10-18 | Apitope Technology Bristol Ltd | Composições compreendendo péptidos de proteína básica de mielina e suas utilizações médicas |
ES2566230T3 (es) * | 2009-10-12 | 2016-04-11 | Lifebio Laboratories Llc | Composición para el tratamiento de la esclerosis múltiple |
GB201300684D0 (en) * | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
GB201603582D0 (en) * | 2016-03-01 | 2016-04-13 | Apitope Int Nv | Peptides |
GB201700095D0 (en) * | 2017-01-04 | 2017-02-22 | Apitope Int Nv | Composition |
AU2018206356A1 (en) * | 2017-01-04 | 2019-07-18 | Worg Pharmaceuticals (Zhejiang) Co., Ltd. | Therapeutic method using tolerogenic peptides |
CA3072867A1 (en) * | 2017-08-14 | 2019-02-21 | Apitope Technology (Bristol) Limited | Method |
WO2022221622A1 (en) | 2021-04-16 | 2022-10-20 | Cour Pharmaceuticals Development Company Inc. | Method of tracking maintenance of immunological tolerance |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
HU230233B1 (hu) * | 2000-08-21 | 2015-10-28 | Apitope Technology (Bristol) Limited | Peptid szelekciós módszer |
US20040096456A1 (en) | 2000-12-01 | 2004-05-20 | Conti-Fine Bianca M | Method to treat hemophilia |
GB0202399D0 (en) * | 2002-02-01 | 2002-03-20 | Univ Bristol | Peptide |
PT2211892E (pt) | 2007-10-31 | 2011-10-18 | Apitope Technology Bristol Ltd | Composições compreendendo péptidos de proteína básica de mielina e suas utilizações médicas |
-
2008
- 2008-10-30 PT PT08844568T patent/PT2211892E/pt unknown
- 2008-10-30 PL PL08844568T patent/PL2211892T3/pl unknown
- 2008-10-30 NZ NZ583924A patent/NZ583924A/en unknown
- 2008-10-30 WO PCT/GB2008/003673 patent/WO2009056833A2/en active Application Filing
- 2008-10-30 JP JP2010530555A patent/JP5361895B2/ja active Active
- 2008-10-30 CN CN2008801138365A patent/CN101848725B/zh active Active
- 2008-10-30 AT AT08844568T patent/ATE518546T1/de active
- 2008-10-30 EP EP08844568A patent/EP2211892B1/de active Active
- 2008-10-30 DK DK08844568.9T patent/DK2211892T3/da active
- 2008-10-30 BR BRPI0818302-3A patent/BRPI0818302B1/pt active IP Right Grant
- 2008-10-30 AU AU2008320657A patent/AU2008320657B2/en active Active
- 2008-10-30 US US12/740,976 patent/US8623827B2/en active Active
- 2008-10-30 KR KR1020107005853A patent/KR101570383B1/ko active IP Right Grant
- 2008-10-30 EA EA201070541A patent/EA017999B1/ru not_active IP Right Cessation
- 2008-10-30 MX MX2010004698A patent/MX2010004698A/es active IP Right Grant
- 2008-10-30 SI SI200830411T patent/SI2211892T1/sl unknown
- 2008-10-30 CA CA2703170A patent/CA2703170C/en active Active
- 2008-10-30 MY MYPI2010001917A patent/MY158800A/en unknown
-
2010
- 2010-03-11 ZA ZA2010/01748A patent/ZA201001748B/en unknown
- 2010-03-22 IL IL204662A patent/IL204662A/en active IP Right Grant
- 2010-05-28 EC EC2010010211A patent/ECSP10010211A/es unknown
- 2010-09-27 HK HK10109209.6A patent/HK1142803A1/xx unknown
-
2011
- 2011-10-06 HR HR20110724T patent/HRP20110724T1/hr unknown
- 2011-10-25 CY CY20111101006T patent/CY1112620T1/el unknown
-
2013
- 2013-12-06 US US14/099,463 patent/US9381234B2/en active Active
-
2016
- 2016-06-03 US US15/173,018 patent/US9775880B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE518546T1 (de) | Zusammensetzungen enthaltend myelin-basisches protein peptiden und medizinische verwendungen | |
EA201001322A1 (ru) | Вакцины против хламидиоза | |
CY1118454T1 (el) | Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες | |
CY1116435T1 (el) | Ενωσεις βορονικου εστερα και φαρμακευτικες συνθεσεις αυτων | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
EA201490644A1 (ru) | Терапевтические пептиды | |
MX2011010353A (es) | Composicion farmaceutica. | |
EA201592264A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
MX2009007661A (es) | Inhibidores de mek. | |
EA201001883A1 (ru) | Мутанты fgf21 и их применение | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
TW201129377A (en) | Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho | |
EA200800667A1 (ru) | Аптамеры, связывающие тромбин с высокой аффинностью | |
EA200870185A1 (ru) | Комбинации ингибиторов ang2 и vegf | |
EA201101521A1 (ru) | Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
MX2009009200A (es) | Tratamiento de enfermedades caracterizadas por la inflamacion. | |
EA201590910A1 (ru) | Белки на основе структурного домена фибронектина, связывающие pcsk9 | |
EA201001204A1 (ru) | Методы и композиции, в которых применяют слитые полипептиды klotho-fgf | |
EA200801930A1 (ru) | Биспецифическая молекула, связывающая tlr9 и cd32 и содержащая t-клеточный эпитоп, для лечения аллергий | |
EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
TN2017000348A1 (en) | Novel proteins specific for pyoverdine and pyochelin | |
CY1110980T1 (el) | Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες | |
NO20083245L (no) | Sykliske antimikrobielle peptider | |
EA201100072A1 (ru) | Новые композиции и способы | |
EA201291050A1 (ru) | Комбинация лекарств с протеинсвязывающими пролекарствами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2211892 Country of ref document: EP |